Central China New Life Limited
HKEX:9983.HK
1.12 (HKD) • At close February 21, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,482.932 | 1,491.388 | 1,353.267 | 1,582.873 | 1,565.268 | 2,035.091 | 1,563.827 | 1,593.313 | 1,061.186 | 1,074.383 | 680.019 | 346.994 | 346.994 | 230.266 | 230.266 |
| Cost of Revenue
| 1,145.083 | 1,113.95 | 973.613 | 1,037.247 | 1,067.698 | 1,353.672 | 1,062.024 | 1,100.106 | 693.676 | 739.912 | 438.206 | 266.653 | 266.653 | 177.634 | 177.634 |
| Gross Profit
| 337.849 | 377.438 | 379.654 | 545.626 | 497.57 | 681.419 | 501.803 | 493.207 | 367.51 | 334.471 | 241.813 | 80.341 | 80.341 | 52.632 | 52.632 |
| Gross Profit Ratio
| 0.228 | 0.253 | 0.281 | 0.345 | 0.318 | 0.335 | 0.321 | 0.31 | 0.346 | 0.311 | 0.356 | 0.232 | 0.232 | 0.229 | 0.229 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 97.73 | 116.247 | 81.584 | 134.371 | 104.461 | 83.895 | 145.772 | 161.29 | 112.076 | 140.93 | 89.381 | 13.441 | 13.441 | 8.635 | 8.635 |
| Selling & Marketing Expenses
| 9.538 | 8.612 | 9.254 | 14.724 | 17.364 | 31.266 | 25.825 | 30.368 | 22.551 | 31.807 | 14.687 | 5.874 | 5.874 | 2.586 | 2.586 |
| SG&A
| 107.268 | 637.85 | 698.654 | 211.005 | 177.674 | 216.66 | 171.597 | 206.916 | 134.627 | 172.737 | 104.068 | 19.315 | 19.315 | 11.221 | 11.221 |
| Other Expenses
| 49.606 | 0 | 5.928 | 12.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.477 | 29.477 | 22.935 | 22.935 |
| Operating Expenses
| 156.874 | 713.548 | 744.069 | 192.26 | 126.363 | 212.029 | 163.549 | 189.309 | 128.597 | 168.119 | 100.271 | 48.792 | 48.792 | 34.156 | 34.156 |
| Operating Income
| 180.975 | -334.119 | -309.769 | 345.534 | 339.733 | 490.97 | 338.88 | 297.726 | 239.075 | 164.926 | 139.083 | 57.585 | 57.585 | 50.351 | 50.351 |
| Operating Income Ratio
| 0.122 | -0.224 | -0.229 | 0.218 | 0.217 | 0.241 | 0.217 | 0.187 | 0.225 | 0.154 | 0.205 | 0.166 | 0.166 | 0.219 | 0.219 |
| Total Other Income Expenses Net
| -0.634 | -0.273 | -52.014 | 15.547 | 58.366 | -9.298 | 5.502 | 18.747 | 1.361 | 3.202 | 0.33 | 4.647 | 4.647 | 8.245 | 8.245 |
| Income Before Tax
| 180.341 | -334.392 | -361.783 | 361.081 | 398.099 | 481.672 | 344.382 | 316.473 | 240.436 | 168.128 | 139.413 | 35.934 | 35.934 | 26.451 | 26.451 |
| Income Before Tax Ratio
| 0.122 | -0.224 | -0.267 | 0.228 | 0.254 | 0.237 | 0.22 | 0.199 | 0.227 | 0.156 | 0.205 | 0.104 | 0.104 | 0.115 | 0.115 |
| Income Tax Expense
| 71.162 | 55.338 | 62.931 | 91.412 | 96.604 | 99.055 | 73.611 | 64.694 | 51.471 | 38.951 | 35.751 | 9.949 | 9.949 | 6.888 | 6.888 |
| Net Income
| 103.394 | -274.759 | -299.61 | 272.445 | 289.815 | 359.391 | 260.168 | 242.773 | 183.814 | 126.037 | 112.971 | 9.736 | 9.736 | 11.706 | 11.706 |
| Net Income Ratio
| 0.07 | -0.184 | -0.221 | 0.172 | 0.185 | 0.177 | 0.166 | 0.152 | 0.173 | 0.117 | 0.166 | 0.028 | 0.028 | 0.051 | 0.051 |
| EPS
| 0.08 | -0.22 | -0.24 | 0.22 | 0.22 | 0.28 | 0.2 | 0.189 | 0.18 | 0.134 | 0.126 | 0.008 | 0.008 | 0.01 | 0.01 |
| EPS Diluted
| 0.081 | -0.22 | -0.24 | 0.22 | 0.22 | 0.28 | 0.2 | 0.188 | 0.18 | 0.14 | 0.126 | 0.008 | 0.008 | 0.01 | 0.01 |
| EBITDA
| 196.447 | -243.627 | -290.283 | 366.626 | 358.973 | 513.149 | 353.14 | 307.991 | 243.844 | 172.532 | 145.529 | 60.944 | 60.944 | 53.573 | 53.573 |
| EBITDA Ratio
| 0.132 | -0.163 | -0.215 | 0.232 | 0.229 | 0.252 | 0.226 | 0.193 | 0.23 | 0.161 | 0.214 | 0.176 | 0.176 | 0.233 | 0.233 |